Holen Sie sich die Stockscreener-App
65.27
3.38%
-2.28
Handel nachbörslich:
65.27
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
12.45%
302.78
|
345.85 | 274.28 | 242.38 | 226.22 |
| Operating Income/Loss |
12.45%
-302.78
|
-345.85 | -274.28 | -242.38 | -226.22 |
| Nonoperating Income/Loss |
26.77%
18.48
|
25.23 | 27.78 | 29.55 | 59.65 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
11.33%
-284.30
|
-320.62 | -246.51 | -212.83 | -166.57 |
| Basic Average Shares |
3.58%
144.49
|
139.51 | - | 136.20 | 136.03 |
| Diluted Average Shares |
3.58%
144.49
|
139.51 | - | 136.20 | 136.03 |
| Basic Earnings Per Share |
14.35%
-1.97
|
-2.30 | - | -1.56 | -1.22 |
| Diluted Earnings Per Share |
14.35%
-1.97
|
-2.30 | - | -1.56 | -1.22 |
0.91%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):